Literature DB >> 18850210

Tools to evaluate estrogenic potency of dietary phytoestrogens:A consensus paper from the EU Thematic Network "Phytohealth" (QLKI-2002-2453).

N M Saarinen1, C Bingham, S Lorenzetti, A Mortensen, S Mäkelä, P Penttinen, I K Sørensen, L M Valsta, F Virgili, G Vollmer, A Wärri, O Zierau.   

Abstract

Phytoestrogens are naturally occurring plantderived polyphenols with estrogenic potency. They are ubiquitous in diet and therefore, generally consumed. Among Europeans, the diet is rich in multiple putative phytoestrogens including flavonoids, tannins, stilbenoids, and lignans. These compounds have been suggested to provide beneficial effects on multiple menopause-related conditions as well as on development of hormone-dependent cancers, which has increased the interest in products and foods with high phytoestrogen content. However, phytoestrogens may as well have adverse estrogenicity related effects similar to any estrogen. Therefore, the assessment of estrogenic potency of dietary compounds is of critical importance. Due to the complex nature of estrogenicity, no single comprehensive test approach is available. Instead, several in vitro and in vivo assays are applied to evaluate estrogenic potency. In vitro estrogen receptor (ER) binding assays provide information on the ability of the compound to I) interact with ERs, II) bind to estrogen responsive element on promoter of the target gene as ligand-ER complex, and III) interact between the co-activator and ERs in ligand-dependent manner. In addition, transactivation assays in cells screen for ligand-induced ERmediated gene activation. Biochemical in vitro analysis can be used to test for possible effects on protein activities and E-screen assays to measure (anti)proliferative response in estrogen responsive cells. However, for assessment of estrogenicity in organs and tissues, in vivo approaches are essential. In females, the uterotrophic assay is applicable for testing ERa agonistic and antagonistic dietary compounds in immature or adult ovariectomized animals. In addition, mammary gland targeted estrogenicity can be detected as stimulated ductal elongation and altered formation of terminal end buds in immature or peripubertal animals. In males, Hershberger assay in peri-pubertal castrated rats can be used to detect (anti)androgenic/ (anti)estrogenic responses in accessory sex glands and other hormone regulated tissues. In addition to these short-term assays, sub-acute and chronic reproductive toxicity assays as well as two-generation studies can be applied for phytoestrogens to confirm their safety in long-term use. For reliable assessment of estrogenicity of dietary phytoestrogens in vivo, special emphasis should be focused on selection of the basal diet, route and doses of administration, and possible metabolic differences between the species used and humans. In conclusion, further development and standardization of the estrogenicity test methods are needed for better interpretation of both the potential benefits and risks of increasing consumption of phytoestrogens from diets and supplements.

Entities:  

Year:  2006        PMID: 18850210      PMCID: PMC3454835          DOI: 10.1007/BF02829964

Source DB:  PubMed          Journal:  Genes Nutr        ISSN: 1555-8932            Impact factor:   5.523


  116 in total

1.  Quantitative characterization of the interaction between purified human estrogen receptor alpha and DNA using fluorescence anisotropy.

Authors:  M Boyer; N Poujol; E Margeat; C A Royer
Journal:  Nucleic Acids Res       Date:  2000-07-01       Impact factor: 16.971

2.  Nuclear receptors have distinct affinities for coactivators: characterization by fluorescence resonance energy transfer.

Authors:  G Zhou; R Cummings; Y Li; S Mitra; H A Wilkinson; A Elbrecht; J D Hermes; J M Schaeffer; R G Smith; D E Moller
Journal:  Mol Endocrinol       Date:  1998-10

3.  Estrogen receptor-beta potency-selective ligands: structure-activity relationship studies of diarylpropionitriles and their acetylene and polar analogues.

Authors:  M J Meyers; J Sun; K E Carlson; G A Marriner; B S Katzenellenbogen; J A Katzenellenbogen
Journal:  J Med Chem       Date:  2001-11-22       Impact factor: 7.446

Review 4.  Advances in the science of estrogen receptor modulation.

Authors:  M J Meegan; D G Lloyd
Journal:  Curr Med Chem       Date:  2003-02       Impact factor: 4.530

5.  Uterine estrogen receptor interaction with estrogen-responsive DNA sequences in vitro: effects of ligand binding on receptor-DNA complexes.

Authors:  S W Curtis; K S Korach
Journal:  Mol Endocrinol       Date:  1990-02

Review 6.  OECD test strategies and methods for endocrine disruptors.

Authors:  H P Gelbke; M Kayser; A Poole
Journal:  Toxicology       Date:  2004-12-01       Impact factor: 4.221

7.  Soy product consumption in 10 European countries: the European Prospective Investigation into Cancer and Nutrition (EPIC) study.

Authors:  L Keinan-Boker; P H M Peeters; A A Mulligan; C Navarro; N Slimani; I Mattisson; E Lundin; A McTaggart; N E Allen; K Overvad; A Tjønneland; F Clavel-Chapelon; J Linseisen; M Haftenberger; P Lagiou; V Kalapothaki; A Evangelista; G Frasca; H B Bueno-de-Mesquita; Y T van der Schouw; D Engeset; G Skeie; M J Tormo; E Ardanaz; U R Charrondière; E Riboli
Journal:  Public Health Nutr       Date:  2002-12       Impact factor: 4.022

8.  Normal sexual development of two strains of rat exposed in utero to low doses of bisphenol A.

Authors:  H Tinwell; J Haseman; P A Lefevre; N Wallis; J Ashby
Journal:  Toxicol Sci       Date:  2002-08       Impact factor: 4.849

9.  Rapid screening of environmental chemicals for estrogen receptor binding capacity.

Authors:  R Bolger; T E Wiese; K Ervin; S Nestich; W Checovich
Journal:  Environ Health Perspect       Date:  1998-09       Impact factor: 9.031

10.  The need to decide if all estrogens are intrinsically similar.

Authors:  Jonathan G Moggs; John Ashby; Helen Tinwell; Fei Ling Lim; David J Moore; Ian Kimber; George Orphanides
Journal:  Environ Health Perspect       Date:  2004-08       Impact factor: 9.031

View more
  5 in total

1.  The association between urinary phytoestrogen excretion and components of the metabolic syndrome in NHANES.

Authors:  Tristan Struja; Aline Richard; Jakob Linseisen; Monika Eichholzer; Sabine Rohrmann
Journal:  Eur J Nutr       Date:  2013-12-31       Impact factor: 5.614

2.  Simple assay for screening phytoestrogenic compounds using the oestrogen receptor immobilised magnetite nanoparticles.

Authors:  Pimchanok Busayapongchai; Sineenat Siri
Journal:  IET Nanobiotechnol       Date:  2017-06       Impact factor: 1.847

Review 3.  Food components and contaminants as (anti)androgenic molecules.

Authors:  Daniele Marcoccia; Marco Pellegrini; Marco Fiocchetti; Stefano Lorenzetti; Maria Marino
Journal:  Genes Nutr       Date:  2017-02-16       Impact factor: 5.523

4.  Manipulating Estrogenic/Anti-Estrogenic Activity of Triphenylethylenes towards Development of Novel Anti-Neoplastic SERMs.

Authors:  Heba E Elnakib; Marian M Ramsis; Nouran O Albably; Merna A Vector; Jan J Weigand; Kai Schwedtmann; Jannette Wober; Oliver Zierau; Günter Vollmer; Ashraf H Abadi; Nermin S Ahmed
Journal:  Int J Mol Sci       Date:  2021-11-22       Impact factor: 5.923

5.  The associations between plasma phytoestrogens concentration and metabolic syndrome risks in Chinese population.

Authors:  Jie Liu; Shengquan Mi; Li Du; Xiang Li; Peiqin Li; Keyu Jia; Jing Zhao; Hong Zhang; Wenhua Zhao; Ying Gao
Journal:  PLoS One       Date:  2018-03-20       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.